By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioMarCare and Ariadne will use a $900,000 grant to develop a protein biomarker-based pharmacogenomic test for predicting which metastatic colorectal cancer patients would respond to treatment.

The companies won the grant from the Binational Industrial Research and Development Foundation (BIRD), said BioMarCare's parent company Hadasit Bio-Holdings, a portfolio of biotech firms based on intellectual property developed and owned by Hadassah University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.